StockData
Hemab Therapeutics Holdings, Inc. logo

Hemab Therapeutics Holdings, Inc. (COAG) stock

COAGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026
$40.86+1.48 (+3.76%)

Close on Nov 13, 2026Market cap $1.91BP/E –Yield –

Hemab Therapeutics statistics

36 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$1.91B
$275.32M
Enterprise Value
$1.48B
$144.91M
PB Ratio
4.45
2.01
P/TBV Ratio
4.45
2.22

Share statisticsIndustry

Float
38M
49M
Shares Held by Insiders
19.5%
11.6%
Shares Held by Institutions
77.5%
56.4%

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
4.56%
-0.80%
Short % of Float
8.79%
8.98%
Short % of Shares Outstanding
7.08%
6.30%
Days to Cover
7.31
5.16

Stock price statisticsIndustry

20-Day Moving Average
$39.54
–
50-Day Moving Average
$37.05
–
Average True Range (14)
$3.56
–
Price Change (1 Week)
-16.6%
-1.15%
Price Change (1 Month)
25.6%
-4.86%
Price Change (3 Months)
-23.8%
-21.1%
Price Change (6 Months)
45.6%
-20.7%
Average Volume (10 Days)
559,016
–
Average Volume (20 Days)
514,782
–
Average Volume (90 Days)
466,751
–
Relative Volume
0.86
0.70
Relative Strength Index (14)
54.0
43.4
Volatility (1 Year)
88.2%
80.1%

Financial positionIndustry

Current Ratio
33.86
3.30
Quick Ratio
33.25
2.39

Balance sheetIndustry

Net Cash (Debt)
$430.24M
$17.80M
Net Cash Per Share
$9.21
$0.80
Equity (Book Value)
$429.27M
$53.27M
Book Value Per Share
$9.19
$1.50
Tangible Book Value
$429.27M
$26.82M
Working Capital
$425.22M
$79.93M

Scores and fair valueIndustry

Altman Z-Score
85.53
0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodCOAGS&P 500DifferenceCOAG per yearS&P 500 per year
1 month+37.1%-3.0%+40.2 pts
3 months-24.3%-2.8%−21.5 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M COAG shares were sold short on Oct 30, 2026, up 4.6% from the previous report, or 8.79% of the shares available to trade. At recent volumes it would take 7.3 days to buy them back. Over the last 20 sessions, 57.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20263,305,474+4.6%451,9557.3
Oct 15, 20263,161,285-6.8%404,7907.8
Sep 30, 20263,390,130+28.4%811,2054.2
Sep 15, 20262,641,038+25.3%350,1127.5
Aug 31, 20262,107,998+3.7%349,4806.0
Aug 14, 20262,032,688-0.3%330,0666.2
Jul 31, 20262,038,062+22.9%479,2114.3
Jul 15, 20261,658,857-3.3%311,2245.3
Jun 30, 20261,714,796+26.6%423,7864.0
Jun 15, 20261,354,937+32.0%179,4417.5
May 29, 20261,026,514+35.3%158,0836.5
May 15, 2026758,697–622,6221.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?